Drug Product Development: Developing With Expertise

Cambrex is dedicated to offering the broadest of small molecule development capabilities to effectively advance your products to market.

Specializing in executing all aspects of the CMC dosage form section of the NDA, our laboratories, pilot facilities, and experts are with you at every stage of the development process. We can take your product through excipient iterations, pre-formulation and formulation activities, through to the manufacture of clinical trial materials and registration batches.

Our analytical services provide the method development and validation support you need for your registration package – flexibly, efficiently and with an excellent FDA, EMEA and Health Canada inspection record.